Status:
COMPLETED
Dexmedetomidine-Propofol and Ketamine-Propofol During Upper Gastrointestinal System Sedation
Lead Sponsor:
Yuzuncu Yil University
Conditions:
Anesthesia; Reaction
Eligibility:
All Genders
18-60 years
Brief Summary
Sedation with dexmedetomidine-propofol or ketamine-propofol was planned in patients with upper gastrointestinal endoscopy.
Detailed Description
Patients between 18 and 60 years in American Society of Anesthesiologists (ASA) I and II groups were included. Patients that had severe organ disease, allergies to study drugs, refused to participate ...
Eligibility Criteria
Inclusion
- ASA I-II group
- 60 patients
- between the ages of 18 and 60
- planned to have upper gastrointestinal system (UGIS) endoscopy with sedation,
Exclusion
- severe heart, lung, liver disease
- kidney failure,
- bleeding diathesis
- fever,
- infection,
- electrolyte disorder such as hypokalemia, hypocalcaemia, acid-base disorder, hypothermia, allergy to drugs to be used, and study those who refused to be included were excluded
Key Trial Info
Start Date :
October 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 13 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04399226
Start Date
October 18 2019
End Date
March 13 2020
Last Update
May 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Van Yuzuncu Yil University
Van, Tuşba, Turkey (Türkiye), 65000